Massachusetts S1573 mandates congenital cytomegalovirus screening for newborns.

Massachusetts S1573 requires the Department of Public Health to implement a congenital cytomegalovirus (cCMV) screening program for newborns. The screening must occur within 21 days of birth and before discharge from the birthing facility. The department may use a saliva or urine PCR test for screening, with a confirmatory urine PCR test if the saliva test is positive. The bill establishes an advisory committee to oversee the program's implementation, consisting of medical professionals and other stakeholders.

Massachusetts S1573 mandates congenital cytomegalovirus screening for newborns.

Massachusetts S1573 requires the Department of Public Health to implement a congenital cytomegalovirus (cCMV) screening program for newborns. The screening must occur within 21 days of birth and before discharge from the birthing facility. The department may use a saliva or urine PCR test for screening, with a confirmatory urine PCR test if the saliva test is positive. The bill establishes an advisory committee to oversee the program's implementation, consisting of medical professionals and other stakeholders.